ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,475,000 | +7.0% | 34,476 | -10.0% | 0.04% | +24.2% |
| Q3 2019 | $1,378,000 | -26.8% | 38,291 | -45.6% | 0.03% | -19.5% |
| Q2 2019 | $1,882,000 | +154.3% | 70,402 | +155.4% | 0.04% | +156.2% |
| Q1 2019 | $740,000 | -43.3% | 27,565 | -65.8% | 0.02% | -52.9% |
| Q4 2018 | $1,304,000 | +127.6% | 80,656 | +215.5% | 0.03% | +78.9% |
| Q2 2014 | $573,000 | -82.7% | 25,561 | -81.2% | 0.02% | -80.2% |
| Q1 2014 | $3,304,000 | – | 135,811 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |